BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo S, Ma B, Jiang X, Li X, Jia Y. Astragalus Polysaccharides Inhibits Tumorigenesis and Lipid Metabolism Through miR-138-5p/SIRT1/SREBP1 Pathway in Prostate Cancer. Front Pharmacol 2020;11:598. [PMID: 32431616 DOI: 10.3389/fphar.2020.00598] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Ni Y, Yang Y, Ran J, Zhang L, Yao M, Liu Z, Zhang L. miR-15a-5p inhibits metastasis and lipid metabolism by suppressing histone acetylation in lung cancer. Free Radic Biol Med 2020;161:150-62. [PMID: 33059020 DOI: 10.1016/j.freeradbiomed.2020.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu Y, Qu HC. miR-138-5p inhibits proliferation and invasion in kidney renal clear cell carcinoma by targeting SINA3 and regulation of the Notch signaling pathway. J Clin Lab Anal 2021;35:e23766. [PMID: 34586647 DOI: 10.1002/jcla.23766] [Reference Citation Analysis]
3 Xu C, Zhang L, Wang D, Jiang S, Cao D, Zhao Z, Huang M, Jin J. Lipidomics reveals that sustained SREBP-1-dependent lipogenesis is a key mediator of gefitinib-acquired resistance in EGFR-mutant lung cancer. Cell Death Discov 2021;7:353. [PMID: 34775471 DOI: 10.1038/s41420-021-00744-1] [Reference Citation Analysis]
4 Li W, Hu X, Li Y, Song K. Cytotoxicity and growth-inhibiting activity of Astragalus polysaccharides against breast cancer via the regulation of EGFR and ANXA1. J Nat Med 2021;75:854-70. [PMID: 34043154 DOI: 10.1007/s11418-021-01525-x] [Reference Citation Analysis]
5 Anjaly K, Tiku AB. MicroRNA mediated therapeutic effects of natural agents in prostate cancer. Mol Biol Rep 2021;48:5759-73. [PMID: 34304390 DOI: 10.1007/s11033-021-06575-8] [Reference Citation Analysis]
6 Sun X, Lu Y, Zhu H, Li R, Zhang D, Pang K. Effects of Psychological Intervention on Perioperative Quality of Life and Serum PSA and FPSA Levels of Patients with Prostate Cancer Treated with Integrated Traditional Chinese and Western Medicine. Evid Based Complement Alternat Med 2021;2021:9286905. [PMID: 34868335 DOI: 10.1155/2021/9286905] [Reference Citation Analysis]
7 Wu H, Wang C, Liu Y, Yang C, Liang X, Zhang X, Li X. miR-138-5p suppresses glioblastoma cell viability and leads to cell cycle arrest by targeting cyclin D3. Oncol Lett 2020;20:264. [PMID: 32989398 DOI: 10.3892/ol.2020.12127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang S, Fu JL, Hao HF, Jiao YN, Li PP, Han SY. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy. Pharmacol Res 2021;170:105728. [PMID: 34119622 DOI: 10.1016/j.phrs.2021.105728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Zhao Q, Lin X, Wang G. Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer. Front Oncol 2022;12:952371. [DOI: 10.3389/fonc.2022.952371] [Reference Citation Analysis]
10 Sheik A, Kim K, Varaprasad GL, Lee H, Kim S, Kim E, Shin JY, Oh SY, Huh YS. The anti-cancerous activity of adaptogenic herb Astragalus membranaceus. Phytomedicine 2021;91:153698. [PMID: 34479785 DOI: 10.1016/j.phymed.2021.153698] [Reference Citation Analysis]
11 Cao H, Wang D, Gao R, Li C, Feng Y, Chen L. Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology. PeerJ 2022;10:e13481. [DOI: 10.7717/peerj.13481] [Reference Citation Analysis]
12 Zhang Q, Huang X. The modulatory properties of Astragalus membranaceus treatment on endometrial cancer: an integrated pharmacological method. PeerJ 2021;9:e11995. [PMID: 34513331 DOI: 10.7717/peerj.11995] [Reference Citation Analysis]
13 Peitzsch C, Gorodetska I, Klusa D, Shi Q, Alves TC, Pantel K, Dubrovska A. Metabolic regulation of prostate cancer heterogeneity and plasticity. Semin Cancer Biol 2020:S1044-579X(20)30261-3. [PMID: 33290846 DOI: 10.1016/j.semcancer.2020.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Wang D, Wang F, Kong X, Li Q, Shi H, Zhao S, Li W, Li Y, Meng J. The role of metabolic reprogramming in cancer metastasis and potential mechanism of traditional Chinese medicine intervention. Biomedicine & Pharmacotherapy 2022;153:113376. [DOI: 10.1016/j.biopha.2022.113376] [Reference Citation Analysis]
15 Shi F, Lu Z, Yang M, Li F, Zhan F, Zhao L, Li Y, Li Q, Li J, Li J, Lin L, Qin Z. Astragalus polysaccharides mediate the immune response and intestinal microbiota in grass carp (Ctenopharyngodon idellus). Aquaculture 2021;534:736205. [DOI: 10.1016/j.aquaculture.2020.736205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
16 Tang X, Li X, Zhang D, Han W. Astragaloside-IV alleviates high glucose-induced ferroptosis in retinal pigment epithelial cells by disrupting the expression of miR-138-5p/Sirt1/Nrf2. Bioengineered 2022;13:8240-54. [PMID: 35302431 DOI: 10.1080/21655979.2022.2049471] [Reference Citation Analysis]
17 Liu L, Yan H, Ruan M, Yang H, Wang L, Lei B, Sun X, Chang C, Huang G, Xie W. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth. Cancer Sci 2021;112:3083-98. [PMID: 34033176 DOI: 10.1111/cas.14988] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Du Y, Wan H, Huang P, Yang J, He Y. A critical review of Astragalus polysaccharides: From therapeutic mechanisms to pharmaceutics. Biomedicine & Pharmacotherapy 2022;147:112654. [DOI: 10.1016/j.biopha.2022.112654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Xu Z, Huang L, Dai T, Pei X, Xia L, Zeng G, Ye M, Liu K, Zeng F, Han W, Jiang S. SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer. Onco Targets Ther 2021;14:4285-95. [PMID: 34335030 DOI: 10.2147/OTT.S315813] [Reference Citation Analysis]
20 Yang F, Xiu M, Yang S, Li X, Tuo W, Su Y, He J, Liu Y. Extension of Drosophila Lifespan by Astragalus polysaccharide through a Mechanism Dependent on Antioxidant and Insulin/IGF-1 Signaling. Evid Based Complement Alternat Med 2021;2021:6686748. [PMID: 33680062 DOI: 10.1155/2021/6686748] [Reference Citation Analysis]
21 Tamang B, Liang Q, Balakrishnan B, Peng S, Zhang W. Astragalus Shiitake—A Novel Functional Food with High Polysaccharide Content and Anti-Proliferative Activity in a Colorectal Carcinoma Cell Line. Nutrients 2022;14:2333. [DOI: 10.3390/nu14112333] [Reference Citation Analysis]
22 You X, Wu Y, Li Q, Sheng W, Zhou Q, Fu W. Astragalus–Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy. Front Pharmacol 2022;13:895696. [DOI: 10.3389/fphar.2022.895696] [Reference Citation Analysis]